Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Treating Asymptomatic Hyperuricemia Could Lower Risk of Developing Chronic Conditions

Martin Garber, DO  |  Issue: August 2016  |  August 12, 2016

In humans, there is a two- to threefold increased risk for hyperuricemia and gout in men and women who consume two or more beverages sweetened by high-fructose corn syrup per day.7,8 Fructose, unlike other sugars, produces uric acid when it is broken down inside cells, leading to elevated serum levels. Modern dietary habits, therefore, likely explain the surge in gout cases and possibly uric acid-related metabolic syndrome.

Uricase (urate oxidase) is an enzyme that catalyzes the oxidation of uric acid to 5-hydroxyisourate, which is then further metabolized and excreted as waste, mostly by the kidneys. Uricase is produced by virtually all organisms from bacteria to mammals. For reasons that until recently remained unknown, humans and modern great apes (i.e., gorillas, orangutans, chimpanzees and bonobos) are the only mammals that do not make uricase. In these species, the uricase gene is present, but inactive. As a result, humans and higher primates have higher serum urate levels than other mammals.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In 2010, Richard Johnson and Peter Andrews proposed a hypothesis that the uricase gene mutation was an evolutionary product of a need for northern migrating apes of 15 million years ago to survive harsh winters.9,10 With fructose-laden fruit as a major dietary component, the primates could benefit from increased available blood sugar and fat from increased insulin resistance. This “thrift gene” would give the brain access to glucose, enabling proper function during times when foraging for food would be most essential. The mutation would survive through the evolution of humans.

The Research

With modern dietary habits and the abundance of available food, the “thrift gene” would lead to pathologic consequences. When uricase is inhibited, rats respond to a fructose challenge by increasing blood pressure and liver fat.11

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In 2006, an elegant study showed that lowering serum uric acid with allopurinol was able to prevent metabolic syndrome in rats fed a fructose-rich diet.12

Hyperuricemia itself may cause metabolic syndrome. A 2012 study followed young adults 18–30 years old for 15 years.13 They showed that hyperuricemia was an independent risk factor for diabetes and pre-diabetes. Several other studies have shown a relationship between hyperuricemia, type II diabetes and insulin resistance.14,15 The mechanism of this relationship is still not clear. Elevated serum insulin levels, as in type II diabetes, cause a decrease in renal uric acid excretion. Insulin requires nitric oxide for glucose uptake in cells. Elevated uric acid levels can then lead to further insulin resistance by directly blocking nitric oxide bioavailability.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:ArthritisdiabetesGouthypertensionhyperuricemiaResearchrheumatologyriskTreatmentUric acidvascular disease

Related Articles

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

    Difficult Gout

    July 1, 2007

    “Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

    Blacks, Asians at Higher Risk for Allopurinol-Related Skin Reactions

    September 8, 2016

    Be careful when prescribing allo­purinol to black and Asian gout patients, a study newly advises. Black and Asian patients who take this ubiquitous, more-than-40-year-old medication are at much higher risk of certain serious skin reactions than are Caucasians or Hispanics. Compared with Caucasians, blacks who take allopurinol to lower blood urate levels have an increased…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences